View Future GrowthMyeco Group 過去の業績過去 基準チェック /06Myeco Groupの収益は年間平均-39.2%の割合で減少していますが、 Chemicals業界の収益は年間 増加しています。収益は年間0.5% 17.4%割合で 減少しています。主要情報-39.22%収益成長率-38.35%EPS成長率Chemicals 業界の成長14.45%収益成長率-17.44%株主資本利益率-48.77%ネット・マージン-25.00%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Mar 02First half 2026 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2025)First half 2026 results: AU$0.003 loss per share (improved from AU$0.004 loss in 1H 2025). Revenue: AU$7.75m (flat on 1H 2025). Net loss: AU$1.66m (loss narrowed 38% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 28Full year 2025 earnings releasedFull year 2025 results: Revenue: AU$15.7m (up 8.6% from FY 2024). Net loss: AU$4.96m (loss narrowed 47% from FY 2024).Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023)Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 23 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 25Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022)Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.Reported Earnings • Feb 17First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022)First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Reported Earnings • Aug 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 50%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesお知らせ • Mar 27Myeco Group Ltd announced that it expects to receive AUD 2 million in fundingMyeco Group Ltd has announced a private placement to issue Unsecured Series Two Convertible Note of the company to raise gross proceeds of AUD 2,000,000 on March 27, 2026. The transaction involves the investor participation of professional and sophisticated investors will be issued under the Company’s 15% placement capacity pursuant to ASX. The notes are 100% convertible into ordinary shares of the company at a conversion price value of AUD 0.019 per share and carry interest rate of 10.5%. The conversion price will be at a 15% discount to the VWAP over 14 trading days preceding the date of the conversion notice. The transaction is subject to approval of the board of directors of the company. The transaction is expected to close on March 31, 2026.Reported Earnings • Mar 02First half 2026 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2025)First half 2026 results: AU$0.003 loss per share (improved from AU$0.004 loss in 1H 2025). Revenue: AU$7.75m (flat on 1H 2025). Net loss: AU$1.66m (loss narrowed 38% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.分析記事 • Jan 15Myeco Group Ltd (ASX:MCO) Shares Fly 29% But Investors Aren't Buying For GrowthMyeco Group Ltd ( ASX:MCO ) shareholders would be excited to see that the share price has had a great month, posting a...New Risk • Jan 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$3.3m free cash flow). Earnings have declined by 49% per year over the past 5 years. Market cap is less than US$10m (AU$7.85m market cap, or US$5.26m). Minor Risk Share price has been volatile over the past 3 months (14% average weekly change).分析記事 • Nov 04Myeco Group Ltd's (ASX:MCO) Prospects Need A Boost To Lift SharesWith a price-to-sales (or "P/S") ratio of 0.5x Myeco Group Ltd ( ASX:MCO ) may be sending very bullish signals at the...お知らせ • Sep 11Myeco Group Ltd, Annual General Meeting, Nov 13, 2025Myeco Group Ltd, Annual General Meeting, Nov 13, 2025.Reported Earnings • Aug 28Full year 2025 earnings releasedFull year 2025 results: Revenue: AU$15.7m (up 8.6% from FY 2024). Net loss: AU$4.96m (loss narrowed 47% from FY 2024).Board Change • Jul 22No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Natalya Jurcheshin was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.分析記事 • Jul 22Myeco Group Ltd's (ASX:MCO) Price Is Right But Growth Is Lacking After Shares Rocket 40%Those holding Myeco Group Ltd ( ASX:MCO ) shares would be relieved that the share price has rebounded 40% in the last...お知らせ • May 06+ 1 more updateMyeco Group Ltd announced that it expects to receive $1.6 million in fundingMyeco Group Ltd announced a private placement that it will issue unsecured convertible notes to sophisticated investors for the aggregate gross proceeds of up to $1,600,000 on May 6, 2025. The Convertible Notes accrue interest at 10.5% per annum paid quarterly over a threeyear term, and are convertible at a 15% discount to the 14-day VWAP at conversion, subject to a maximum conversion price of $0.05 and a minimum conversion price of $0.019 per share. Conversion is permitted twelve months after the draw down date, with mandatory conversion at maturity. The Company may redeem the Convertible Notes in whole or in part at any time, with 30 days notice to noteholders who may convert all or part of their outstanding principal and accrued interest during this 30 day notice period.お知らせ • Apr 23MyEco Group Ltd Provides an Update on Its Operational Restructure InitiativesMyEco Group Ltd. provided an update on its operational restructure initiatives. On 10 February 2025, the Company announced a strategic review of its manufacturing and production operations to support its record MyEco® branded sales growth more cost effectively, and to reposition the cost base of its manufacturing and production supply chain. The following initiatives from the operational restructure are all expected to be completed by June 2025: The ability to scale production capacity through strategic partnerships with high- end converters in south-east Asia, to reduce production costs, increase redundancy of supply chains, and increase flexibility to meet demand in different geographies - Reduced cost from the rationalisation of manufacturing assets in Malaysia - Relocation of larger pilot production equipment from Melbourne to the company's commercial plant in Nanjing, China to reduce costs for new product trials and realise efficiencies in upscaling to commercial production. Relocation of the company's head office and product development centre to lower-cost premises within Melbourne to reduce both rent and overheads The implementation of these initiatives is expected to deliver annual fixed cost savings of circa $2.5 million to $3.0 million commencing in the first quarter of fiscal year 2026. They will streamline MyEco Group's operations and scale production more efficiently with an aim to improve product margins, while minimising the requirement for capital investment. The company's fully integrated approach, utilising internal assets and key partnerships, positions MyEco Group to meet increasing demand in a cost-effective manner while maintaining the high-quality standards that the brand is known for.お知らせ • Feb 10+ 1 more updateMyeco Group Ltd Provides Earnings Guidance for the Second Half of Fiscal Year 2025Myeco Group Ltd. provided earnings guidance for the second half of fiscal year 2025. The Company expects its strategic repositioning and operational restructuring to reduce costs materially, with increased flexibility to scale production through the use of strategic partners better aligned to support sales growth expected in the second half of fiscal year 2025 and beyond.New Risk • Dec 06New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$13.7m (US$8.81m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (AU$13.7m market cap, or US$8.81m).お知らせ • Sep 19SECOS Group Limited, Annual General Meeting, Nov 14, 2024SECOS Group Limited, Annual General Meeting, Nov 14, 2024.Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023)Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 23 percentage points per year, which is a significant difference in performance.New Risk • Aug 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$12.5m market cap, or US$8.23m). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change).分析記事 • Jul 14Revenues Working Against SECOS Group Limited's (ASX:SES) Share Price Following 26% DiveThe SECOS Group Limited ( ASX:SES ) share price has fared very poorly over the last month, falling by a substantial...New Risk • Jun 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$14.9m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$14.9m market cap, or US$9.92m).分析記事 • Dec 27Lacklustre Performance Is Driving SECOS Group Limited's (ASX:SES) 27% Price DropSECOS Group Limited ( ASX:SES ) shareholders that were waiting for something to happen have been dealt a blow with a...お知らせ • Sep 26SECOS Group Limited, Annual General Meeting, Nov 17, 2023SECOS Group Limited, Annual General Meeting, Nov 17, 2023, at 10:00 AUS Eastern Standard Time.Reported Earnings • Aug 25Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022)Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.New Risk • Aug 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (AU$35.0m market cap, or US$22.4m).分析記事 • Jun 17There's No Escaping SECOS Group Limited's (ASX:SES) Muted RevenuesYou may think that with a price-to-sales (or "P/S") ratio of 1.2x SECOS Group Limited ( ASX:SES ) is definitely a stock...お知らせ • May 25SECOS Group Limited Appoints Natalya Jurcheshin as Non-Executive DirectorSECOS Group Limited announced the appointment of experienced company director and senior leader Natalya Jurcheshin to its Board as a Non-Executive Director. Ms Jurcheshin brings over twenty years' experience spanning finance, operations and strategy throughout Australia, North America, Ukraine and Russia in professional services, private and public companies, start-ups, and SMEs. Ms. Jurcheshin is a Non-Executive Director of Adacel Technologies Limited where she is the Chair of the Audit & Risk Management Committee and Remuneration Committee. She is a former CFO, Head of Operations and Company Secretary of Circadian Technologies Limited (renamed Opthea Limited) and is a qualified chartered accountant. Ms Jurcheshin has leadership experience in finance and accounting, risk management, strategy, operations, audit and assurance services and board roles. Her diverse commercial experience includes other senior roles with Antisense Therapeutics Limited Melbourne Symphony Orchestra, Arthur Andersen (now part of Ernst & Young) and NEISS Group Pty Ltd.分析記事 • Mar 02Here's Why We're Not At All Concerned With SECOS Group's (ASX:SES) Cash Burn SituationEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...お知らせ • Feb 20SECOS Group Limited Launches New 95% Certified Recycled MyEcoBagThe Board of SECOS Group Limited provided the market with an update on the launch of its new 95% Certified Recycled MyEco range of products. SECOS Group Limited launches a new recycled MyEco bin liner range produced from 95% soft-plastic Post-Consumer Waste which has been certified to meet Global Recycle Standards for recycling content, chain of custody, social and environmental practices, and chemical restrictions. Unlike many recycled products that are not produced from Post- Consumer Waste, MyEc recycled products offer a genuine recycling solution for soft plastics without compromising quality. The products will be offered for sale as part of the Group's MyEco range of products and will target the growing recycled product market segment, to reduce the amount of virgin plastic finding its way into environment and to reduce petroleum consumption and CO2 emissions. SECOS Group, an Australian company, will produce the MyEco 95% Recycled range in the Company's Asian manufacturing plants. The expanded range further aligns SECOS insupporting the Australian Government's environmental policy of "Reuse, Recycle or Compost" as stated in the Australian National Plastic Plan and mirrors policy in many other key markets around the world in the fight to reducing the amount of single use plastic in environment.Reported Earnings • Feb 17First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022)First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings.お知らせ • Jan 27+ 1 more updateSECOS Group Limited Announces CEO ChangesSECOS Group Limited announced changes to its CEO Position. Current SECOS Executive Chairman, Mr. Richard Tegoni will take on the role of CEO. The changes will be effective from 1 February 2023. After four years as SECOS CEO, Mr. Ian Stacey will step down to focus on sales and strategic partnership development including working with Industry participants and corporate development opportunities. Mr. Tegoni has served as Executive Chairman on the SECOS Board since October 2013 and brings over ten years' experience in the biopolymer industry together with experience in several senior executive roles across a range of industries. Mr. Tegoni was a very early-stage investor into the biopolymer industry and has guided the business from a small start up to become a global player in compostable products and technology making him an ideal person to take the helm as CEO and lead the Company on its next stage of growth.Price Target Changed • Nov 16Price target decreased to AU$0.17Down from AU$0.20, the current price target is provided by 1 analyst. New target price is 31% above last closing price of AU$0.13. Stock is down 59% over the past year. The company is forecast to post a net loss per share of AU$0.001 next year compared to a net loss per share of AU$0.0058 last year.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.分析記事 • Nov 01Here's Why We're Not Too Worried About SECOS Group's (ASX:SES) Cash Burn SituationThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...お知らせ • Oct 26SECOS Group Limited, Annual General Meeting, Nov 30, 2022SECOS Group Limited, Annual General Meeting, Nov 30, 2022, at 10:00 AUS Eastern Standard Time.Reported Earnings • Aug 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 50%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.分析記事 • Jul 15What Does SECOS Group Limited's (ASX:SES) Share Price Indicate?While SECOS Group Limited ( ASX:SES ) might not be the most widely known stock at the moment, it saw significant share...Price Target Changed • Jul 12Price target decreased to AU$0.20Down from AU$0.29, the current price target is provided by 1 analyst. New target price is 60% above last closing price of AU$0.13. Stock is down 62% over the past year. The company is forecast to post a net loss per share of AU$0.004 compared to earnings per share of AU$0.0051 last year.Board Change • Jul 12No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. No independent directors (5 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Jun 17SECOS Group Limited Announces the Retirement of David Wake as a Non-Executive Director on 30 June 2022The Board of SECOS Group Limited announced that Mr. David Wake will retire as a Non-Executive Director on 30 June 2022. Mr. Wake has served the Company for four years since his appointment on 16 July 2018 and during that time contributed significantly to SECOS' strategic direction, governance and provided valuable advice on industry matters.お知らせ • May 16+ 1 more updateSECOS Group Limited Appoints Colin Lai Has Been as Chief Financial OfficerSECOS Group Limited announced that Mr. Colin Lai has been appointed as Chief Financial Officer effective 14 June 2022. Colin is a finance and accounting professional with extensive experience in FMCG, financial and software services sectors with public-listed and multinational companies. His most recent role was as Group Financial Controller at BWX Limited with previous group finance roles at National Australia Bank, Iress Ltd. and Treasury Wine Estates.In his BWX role, Colin led a Global Finance Team, and was involved in high level strategic planning and financial decisions, equity raises, and conducting due diligence and financial reviews in connection with acquisitions. He was also involved in successful negotiations of Group debt facilities to support growth initiatives. Colin has managed key areas of finance including financial control and reporting and has significant experience in preparing Group budgets, sales forecasts, analyzing the profitability of new products, evaluation of marketing campaigns, and detailed reviews of marketing and supply chain contracts.お知らせ • May 12SECOS Group Ordinary Shares to Be Deleted from Other OTCSECOS Group Limited Ordinary Shares will be deleted from Other OTC effective from May 11, 2022, due to Inactive Security.お知らせ • Apr 20Woolworths Expands SECOS Products to 970 StoresThe Board of SECOS Group provided the market with an update on progress of its MyEcoBag® commercialisation activities. MyEcoTM success within Woolworths stores, together with the expansion into other distributors and retail chains supports the Board's strategic investment decision to expand in the retail market and the extra investment incurred in FY22. These investments are expected to achieve positive returns in the coming year. The availability of SECOS' compostable bags via Woolworths stores will give more households participating in approved council food organic waste programs the option to dispose of the bags and food waste in their green waste bin. The use of SECOS' compostable bags offers households a clean and convenient way to assist with the separation of their food waste which is critical to ensure food does not end up in landfill. The success of MyEcoTM branded products is becoming a material subcategory within the Company's total bioplastic bag sales. The expansion into 970 Woolworths stores has validated the Board's decision to invest extra funds into developing a global retail brand during a period when the Company was experiencing a range of global challenges (Covid-19 related rising freight and input costs, shipping delays, Covid lockdowns in some ports and severe floods experienced at one of the Company's manufacturing hubs). SECOS will continue to execute its growth strategy and expects returns to flow through to the bottom line as trading conditions normalize. The Company will also benefit from improving economies of scale through increased utilisation of the Company's new Malaysian plant which was launched in January this year. SECOS continues to develop further opportunities for growth in new markets for its branded MyEcoBag® and MyEcoPet® line of products and is working to garner market share in grocery and convenience stores in Australia, the USA, Latin America and elsewhere.お知らせ • Apr 14+ 1 more updateEdmond Tern Decides to Leave SECOS Group Limited as Chief Financial OfficerSECOS Group Limited announced that Mr. Edmond Tern, Chief Financial Officer & Company Secretary, has decided to leave SECOS to pursue other opportunities in early July 2022. An orderly transition including a search for a new CFO & Company Secretary is currently underway.お知らせ • Apr 12SECOS Group Limited Announces Change of Corporate Head Office AddressSECOS Group Limited announced that it has relocated its corporate head office to Mount Waverley, Victoria. The new head office will be co-located with the company's new Global Bioplastics Research and Development Centre.Major Estimate Revision • Mar 03Consensus revenue estimates fall by 10%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from AU$43.0m to AU$38.5m. Forecast losses increased from AU$0.01 to AU$0 per share. Chemicals industry in Australia expected to see average net income growth of 33% next year. Consensus price target down from AU$0.45 to AU$0.40. Share price rose 10% to AU$0.27 over the past week.分析記事 • Feb 28One SECOS Group Limited (ASX:SES) Broker Just Cut Their Revenue Forecasts By 10%The analyst covering SECOS Group Limited ( ASX:SES ) delivered a dose of negativity to shareholders today, by making a...お知らせ • Jan 24SECOS Launches MyEcoBag® & MyEcoPet® Through Pacchini Sales & DistributionSECOS Group Limited provided the market with an update on progress of its MyEcoBag® and MyEcoPet® commercialization activities. SECOS is launching new MyEcoPet® SKU's with Pacchini consisting of the two-roll pack plus dispenser and the four-roll pack. With nearly 5 million dogs in Australia and approximately 40% of Australian households owning a dog, SECOS will begin to penetrate independent Stores backed by a well-known and reputable distributor such as Pachinni. Additionally, Pacchini will launch two new bin-liner SKU's into food waste diversion market, a certified compostable 12 litre and 28 litre bin liner SKU's, adding to their existing 8 litre and 36 litre SKU's currently available through Woolworths stores.分析記事 • Oct 05SECOS Group (ASX:SES) Might Have The Makings Of A Multi-BaggerThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...分析記事 • Sep 02We Think Shareholders Should Be Aware Of Some Factors Beyond SECOS Group's (ASX:SES) ProfitAfter announcing healthy earnings, SECOS Group Limited's ( ASX:SES ) stock rose over the last week. However, we think...Reported Earnings • Aug 13Full year 2021 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$30.1m (up 43% from FY 2020). Net income: AU$2.59m (up AU$3.78m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue.Breakeven Date Change • Jun 30Forecast breakeven pushed back to 2022The analyst covering SECOS Group previously expected the company to break even in 2021. New forecast suggests the company will make a profit of AU$5.70m in 2022. Average annual earnings growth of 103% is required to achieve expected profit on schedule.分析記事 • Jun 07We Think SECOS Group (ASX:SES) Can Easily Afford To Drive Business GrowthWe can readily understand why investors are attracted to unprofitable companies. For example, SECOS Group ( ASX:SES...Price Target Changed • May 05Price target increased to AU$0.37Up from AU$0.28, the current price target is an average from 2 analysts. New target price is 72% above last closing price of AU$0.21. Stock is up 264% over the past year.分析記事 • Apr 06We Might See A Profit From SECOS Group Limited (ASX:SES) SoonWe feel now is a pretty good time to analyse SECOS Group Limited's ( ASX:SES ) business as it appears the company may...分析記事 • Mar 15Imagine Holding SECOS Group (ASX:SES) Shares While The Price Zoomed 409% HigherIt might be of some concern to shareholders to see the SECOS Group Limited ( ASX:SES ) share price down 18% in the last...Recent Insider Transactions • Mar 04Executive Director recently bought AU$307k worth of stockOn the 2nd of March, Stephen Walters bought around 1m shares on-market at roughly AU$0.31 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$636k more in shares than they bought in the last 12 months.Price Target Changed • Feb 24Price target raised to AU$0.28Up from AU$0.23, the current price target is an average from 2 analysts. The new target price is 8.1% below the current share price of AU$0.31. As of last close, the stock is up 313% over the past year.Analyst Estimate Surprise Post Earnings • Feb 23Revenue beats expectations, earnings disappointRevenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 90%. Over the next year, revenue is forecast to grow 50%, compared to a 15% growth forecast for the Chemicals industry in Australia.分析記事 • Feb 22Should You Think About Buying SECOS Group Limited (ASX:SES) Now?While SECOS Group Limited ( ASX:SES ) might not be the most widely known stock at the moment, it received a lot of...Is New 90 Day High Low • Feb 10New 90-day high: AU$0.35The company is up 100% from its price of AU$0.17 on 12 November 2020. The Australian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share.分析記事 • Feb 05Richard Tegoni Is The Executive Chairman of SECOS Group Limited (ASX:SES) And They Just Picked Up 63% More SharesThose following along with SECOS Group Limited ( ASX:SES ) will no doubt be intrigued by the recent purchase of shares...Recent Insider Transactions • Feb 05Executive Chairman recently bought AU$60k worth of stockOn the 4th of February, Richard Tegoni bought around 200k shares on-market at roughly AU$0.30 per share. This was the largest purchase by an insider in the last 3 months. This was Richard's only on-market trade for the last 12 months.Is New 90 Day High Low • Jan 21New 90-day high: AU$0.24The company is up 48% from its price of AU$0.17 on 23 October 2020. The Australian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.49 per share.分析記事 • Jan 19Read This Before Buying SECOS Group Limited (ASX:SES) SharesWe've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...Is New 90 Day High Low • Jan 06New 90-day high: AU$0.21The company is up 19% from its price of AU$0.18 on 08 October 2020. The Australian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share.分析記事 • Dec 15If You Had Bought SECOS Group (ASX:SES) Stock Three Years Ago, You Could Pocket A 100% Gain TodayBy buying an index fund, investors can approximate the average market return. But if you pick the right individual...Is New 90 Day High Low • Nov 18New 90-day high: AU$0.20The company is up 24% from its price of AU$0.17 on 20 August 2020. The Australian market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.44 per share.お知らせ • Sep 24SECOS Group Limited Secures a Strategic Distribution Agreement with Infinite Source of IdeasSECOS Group Limited (‘the Company’) announced that it has secured a strategic distribution agreement with ISOI ‘Infinite Source Of Ideas’. Under the agreement, ISOI will act as the Company's exclusive distributor in Latin America for the sale of CardiaTM Bioplastic resins to local converters. ISOI have already supplied several convertors with CardiaTM resins who have produced compostable bags for major local retailers. Distribution and trials of resins to local converters has resulted in a ramp up of demand with initial commercial orders exceeding $1.5m and due for delivery in the December quarter.お知らせ • Sep 17SECOS Group Limited announced that it has received AUD 14.861974 million in fundingOn September 16, 2020, SECOS Group Limited (ASX:SES) closed the transaction. The company issued 87,423,379 ordinary fully paid shares for gross proceeds of AUD 14,861,974.43 in the transaction. The transaction included participation from individual investor Don Haller Jr. for 811,920 shares for AUD 138,026.40 and other investors.お知らせ • Sep 09SECOS Group Limited announced that it expects to receive AUD 15.0008 million in fundingSECOS Group Limited (ASX:SES) announced private placement of 88,240,000 shares at a price of AUD 0.17 per share for gross proceeds of AUD 15,000,800 on September 9, 2020. The transaction will include participation from leading institutions and existing shareholders and a wide group of institutional investors including Don Haller Jr. for $100,000 (AUD 138,402.60), subject to approval of shareholders at annual general meeting. The transaction is expected to settle on September 14, 2020. The transaction has been approved by the board of directors of the company. The transaction was oversubscribed.お知らせ • Aug 16SECOS Group Limited to Report Q4, 2020 Results on Aug 27, 2020SECOS Group Limited announced that they will report Q4, 2020 results at 10:18 PM, GMT Standard Time on Aug 27, 2020分析記事 • Aug 11SECOS Group Limited (ASX:SES) Insiders Increased Their HoldingsIt is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...分析記事 • Aug 11Breakeven On The Horizon For SECOS Group Limited (ASX:SES)SECOS Group Limited's (ASX:SES): SECOS Group Limited manufactures and distributes sustainable packaging materials...収支内訳Myeco Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史ASX:MCO 収益、費用、利益 ( )AUD Millions日付収益収益G+A経費研究開発費31 Dec 2516-47030 Sep 2516-48030 Jun 2516-58031 Mar 2516-78031 Dec 2416-98030 Sep 2415-97030 Jun 2414-97031 Mar 2414-87031 Dec 2314-77030 Sep 2315-77030 Jun 2316-67031 Mar 2320-66031 Dec 2223-56030 Sep 2227-46030 Jun 2231-36031 Mar 2231-15031 Dec 213225030 Sep 213125030 Jun 213034031 Mar 212714031 Dec 202404030 Sep 2023-14030 Jun 2021-14031 Mar 2021-24031 Dec 1921-24030 Sep 1921-35030 Jun 1921-46031 Mar 1922-46031 Dec 1823-46030 Sep 1823-46030 Jun 1824-36031 Mar 1823-35031 Dec 1723-35030 Sep 1723-35030 Jun 1722-35031 Dec 1621-45030 Sep 1621-45030 Jun 1621-55031 Dec 1519-44130 Sep 1518-430質の高い収益: MCOは現在利益が出ていません。利益率の向上: MCOは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: MCOは利益が出ておらず、過去 5 年間で損失は年間39.2%の割合で増加しています。成長の加速: MCOの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: MCOは利益が出ていないため、過去 1 年間の収益成長をChemicals業界 ( 6.5% ) と比較することは困難です。株主資本利益率高いROE: MCOは現在利益が出ていないため、自己資本利益率 ( -48.77% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/10 16:08終値2026/07/10 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Myeco Group Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Aaron MullerCanaccord GenuityHeath AndrewsPAC Partners Securities Pty. Ltd.
Reported Earnings • Mar 02First half 2026 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2025)First half 2026 results: AU$0.003 loss per share (improved from AU$0.004 loss in 1H 2025). Revenue: AU$7.75m (flat on 1H 2025). Net loss: AU$1.66m (loss narrowed 38% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 28Full year 2025 earnings releasedFull year 2025 results: Revenue: AU$15.7m (up 8.6% from FY 2024). Net loss: AU$4.96m (loss narrowed 47% from FY 2024).
Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023)Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 23 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 25Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022)Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
Reported Earnings • Feb 17First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022)First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Reported Earnings • Aug 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 50%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 27Myeco Group Ltd announced that it expects to receive AUD 2 million in fundingMyeco Group Ltd has announced a private placement to issue Unsecured Series Two Convertible Note of the company to raise gross proceeds of AUD 2,000,000 on March 27, 2026. The transaction involves the investor participation of professional and sophisticated investors will be issued under the Company’s 15% placement capacity pursuant to ASX. The notes are 100% convertible into ordinary shares of the company at a conversion price value of AUD 0.019 per share and carry interest rate of 10.5%. The conversion price will be at a 15% discount to the VWAP over 14 trading days preceding the date of the conversion notice. The transaction is subject to approval of the board of directors of the company. The transaction is expected to close on March 31, 2026.
Reported Earnings • Mar 02First half 2026 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2025)First half 2026 results: AU$0.003 loss per share (improved from AU$0.004 loss in 1H 2025). Revenue: AU$7.75m (flat on 1H 2025). Net loss: AU$1.66m (loss narrowed 38% from 1H 2025). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
分析記事 • Jan 15Myeco Group Ltd (ASX:MCO) Shares Fly 29% But Investors Aren't Buying For GrowthMyeco Group Ltd ( ASX:MCO ) shareholders would be excited to see that the share price has had a great month, posting a...
New Risk • Jan 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$3.3m free cash flow). Earnings have declined by 49% per year over the past 5 years. Market cap is less than US$10m (AU$7.85m market cap, or US$5.26m). Minor Risk Share price has been volatile over the past 3 months (14% average weekly change).
分析記事 • Nov 04Myeco Group Ltd's (ASX:MCO) Prospects Need A Boost To Lift SharesWith a price-to-sales (or "P/S") ratio of 0.5x Myeco Group Ltd ( ASX:MCO ) may be sending very bullish signals at the...
お知らせ • Sep 11Myeco Group Ltd, Annual General Meeting, Nov 13, 2025Myeco Group Ltd, Annual General Meeting, Nov 13, 2025.
Reported Earnings • Aug 28Full year 2025 earnings releasedFull year 2025 results: Revenue: AU$15.7m (up 8.6% from FY 2024). Net loss: AU$4.96m (loss narrowed 47% from FY 2024).
Board Change • Jul 22No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Non-Executive Director Natalya Jurcheshin was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
分析記事 • Jul 22Myeco Group Ltd's (ASX:MCO) Price Is Right But Growth Is Lacking After Shares Rocket 40%Those holding Myeco Group Ltd ( ASX:MCO ) shares would be relieved that the share price has rebounded 40% in the last...
お知らせ • May 06+ 1 more updateMyeco Group Ltd announced that it expects to receive $1.6 million in fundingMyeco Group Ltd announced a private placement that it will issue unsecured convertible notes to sophisticated investors for the aggregate gross proceeds of up to $1,600,000 on May 6, 2025. The Convertible Notes accrue interest at 10.5% per annum paid quarterly over a threeyear term, and are convertible at a 15% discount to the 14-day VWAP at conversion, subject to a maximum conversion price of $0.05 and a minimum conversion price of $0.019 per share. Conversion is permitted twelve months after the draw down date, with mandatory conversion at maturity. The Company may redeem the Convertible Notes in whole or in part at any time, with 30 days notice to noteholders who may convert all or part of their outstanding principal and accrued interest during this 30 day notice period.
お知らせ • Apr 23MyEco Group Ltd Provides an Update on Its Operational Restructure InitiativesMyEco Group Ltd. provided an update on its operational restructure initiatives. On 10 February 2025, the Company announced a strategic review of its manufacturing and production operations to support its record MyEco® branded sales growth more cost effectively, and to reposition the cost base of its manufacturing and production supply chain. The following initiatives from the operational restructure are all expected to be completed by June 2025: The ability to scale production capacity through strategic partnerships with high- end converters in south-east Asia, to reduce production costs, increase redundancy of supply chains, and increase flexibility to meet demand in different geographies - Reduced cost from the rationalisation of manufacturing assets in Malaysia - Relocation of larger pilot production equipment from Melbourne to the company's commercial plant in Nanjing, China to reduce costs for new product trials and realise efficiencies in upscaling to commercial production. Relocation of the company's head office and product development centre to lower-cost premises within Melbourne to reduce both rent and overheads The implementation of these initiatives is expected to deliver annual fixed cost savings of circa $2.5 million to $3.0 million commencing in the first quarter of fiscal year 2026. They will streamline MyEco Group's operations and scale production more efficiently with an aim to improve product margins, while minimising the requirement for capital investment. The company's fully integrated approach, utilising internal assets and key partnerships, positions MyEco Group to meet increasing demand in a cost-effective manner while maintaining the high-quality standards that the brand is known for.
お知らせ • Feb 10+ 1 more updateMyeco Group Ltd Provides Earnings Guidance for the Second Half of Fiscal Year 2025Myeco Group Ltd. provided earnings guidance for the second half of fiscal year 2025. The Company expects its strategic repositioning and operational restructuring to reduce costs materially, with increased flexibility to scale production through the use of strategic partners better aligned to support sales growth expected in the second half of fiscal year 2025 and beyond.
New Risk • Dec 06New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$13.7m (US$8.81m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Earnings have declined by 39% per year over the past 5 years. Market cap is less than US$10m (AU$13.7m market cap, or US$8.81m).
お知らせ • Sep 19SECOS Group Limited, Annual General Meeting, Nov 14, 2024SECOS Group Limited, Annual General Meeting, Nov 14, 2024.
Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.016 loss per share (vs AU$0.012 loss in FY 2023)Full year 2024 results: AU$0.016 loss per share (further deteriorated from AU$0.012 loss in FY 2023). Revenue: AU$14.4m (down 37% from FY 2023). Net loss: AU$9.42m (loss widened 40% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 23 percentage points per year, which is a significant difference in performance.
New Risk • Aug 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Australian stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$12.5m market cap, or US$8.23m). Minor Risk Share price has been volatile over the past 3 months (12% average weekly change).
分析記事 • Jul 14Revenues Working Against SECOS Group Limited's (ASX:SES) Share Price Following 26% DiveThe SECOS Group Limited ( ASX:SES ) share price has fared very poorly over the last month, falling by a substantial...
New Risk • Jun 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: AU$14.9m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Market cap is less than US$10m (AU$14.9m market cap, or US$9.92m).
分析記事 • Dec 27Lacklustre Performance Is Driving SECOS Group Limited's (ASX:SES) 27% Price DropSECOS Group Limited ( ASX:SES ) shareholders that were waiting for something to happen have been dealt a blow with a...
お知らせ • Sep 26SECOS Group Limited, Annual General Meeting, Nov 17, 2023SECOS Group Limited, Annual General Meeting, Nov 17, 2023, at 10:00 AUS Eastern Standard Time.
Reported Earnings • Aug 25Full year 2023 earnings released: AU$0.012 loss per share (vs AU$0.006 loss in FY 2022)Full year 2023 results: AU$0.012 loss per share (further deteriorated from AU$0.006 loss in FY 2022). Revenue: AU$22.8m (down 26% from FY 2022). Net loss: AU$6.75m (loss widened 119% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
New Risk • Aug 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Shareholders have been diluted in the past year (11% increase in shares outstanding). Market cap is less than US$100m (AU$35.0m market cap, or US$22.4m).
分析記事 • Jun 17There's No Escaping SECOS Group Limited's (ASX:SES) Muted RevenuesYou may think that with a price-to-sales (or "P/S") ratio of 1.2x SECOS Group Limited ( ASX:SES ) is definitely a stock...
お知らせ • May 25SECOS Group Limited Appoints Natalya Jurcheshin as Non-Executive DirectorSECOS Group Limited announced the appointment of experienced company director and senior leader Natalya Jurcheshin to its Board as a Non-Executive Director. Ms Jurcheshin brings over twenty years' experience spanning finance, operations and strategy throughout Australia, North America, Ukraine and Russia in professional services, private and public companies, start-ups, and SMEs. Ms. Jurcheshin is a Non-Executive Director of Adacel Technologies Limited where she is the Chair of the Audit & Risk Management Committee and Remuneration Committee. She is a former CFO, Head of Operations and Company Secretary of Circadian Technologies Limited (renamed Opthea Limited) and is a qualified chartered accountant. Ms Jurcheshin has leadership experience in finance and accounting, risk management, strategy, operations, audit and assurance services and board roles. Her diverse commercial experience includes other senior roles with Antisense Therapeutics Limited Melbourne Symphony Orchestra, Arthur Andersen (now part of Ernst & Young) and NEISS Group Pty Ltd.
分析記事 • Mar 02Here's Why We're Not At All Concerned With SECOS Group's (ASX:SES) Cash Burn SituationEven when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
お知らせ • Feb 20SECOS Group Limited Launches New 95% Certified Recycled MyEcoBagThe Board of SECOS Group Limited provided the market with an update on the launch of its new 95% Certified Recycled MyEco range of products. SECOS Group Limited launches a new recycled MyEco bin liner range produced from 95% soft-plastic Post-Consumer Waste which has been certified to meet Global Recycle Standards for recycling content, chain of custody, social and environmental practices, and chemical restrictions. Unlike many recycled products that are not produced from Post- Consumer Waste, MyEc recycled products offer a genuine recycling solution for soft plastics without compromising quality. The products will be offered for sale as part of the Group's MyEco range of products and will target the growing recycled product market segment, to reduce the amount of virgin plastic finding its way into environment and to reduce petroleum consumption and CO2 emissions. SECOS Group, an Australian company, will produce the MyEco 95% Recycled range in the Company's Asian manufacturing plants. The expanded range further aligns SECOS insupporting the Australian Government's environmental policy of "Reuse, Recycle or Compost" as stated in the Australian National Plastic Plan and mirrors policy in many other key markets around the world in the fight to reducing the amount of single use plastic in environment.
Reported Earnings • Feb 17First half 2023 earnings released: AU$0.005 loss per share (vs AU$0.001 loss in 1H 2022)First half 2023 results: AU$0.005 loss per share (further deteriorated from AU$0.001 loss in 1H 2022). Revenue: AU$11.8m (down 23% from 1H 2022). Net loss: AU$2.48m (loss widened 214% from 1H 2022). Revenue is forecast to grow 34% p.a. on average during the next 2 years, compared to a 8.2% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
お知らせ • Jan 27+ 1 more updateSECOS Group Limited Announces CEO ChangesSECOS Group Limited announced changes to its CEO Position. Current SECOS Executive Chairman, Mr. Richard Tegoni will take on the role of CEO. The changes will be effective from 1 February 2023. After four years as SECOS CEO, Mr. Ian Stacey will step down to focus on sales and strategic partnership development including working with Industry participants and corporate development opportunities. Mr. Tegoni has served as Executive Chairman on the SECOS Board since October 2013 and brings over ten years' experience in the biopolymer industry together with experience in several senior executive roles across a range of industries. Mr. Tegoni was a very early-stage investor into the biopolymer industry and has guided the business from a small start up to become a global player in compostable products and technology making him an ideal person to take the helm as CEO and lead the Company on its next stage of growth.
Price Target Changed • Nov 16Price target decreased to AU$0.17Down from AU$0.20, the current price target is provided by 1 analyst. New target price is 31% above last closing price of AU$0.13. Stock is down 59% over the past year. The company is forecast to post a net loss per share of AU$0.001 next year compared to a net loss per share of AU$0.0058 last year.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 1 highly experienced director. No independent directors (4 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
分析記事 • Nov 01Here's Why We're Not Too Worried About SECOS Group's (ASX:SES) Cash Burn SituationThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
お知らせ • Oct 26SECOS Group Limited, Annual General Meeting, Nov 30, 2022SECOS Group Limited, Annual General Meeting, Nov 30, 2022, at 10:00 AUS Eastern Standard Time.
Reported Earnings • Aug 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: AU$0.006 loss per share (down from AU$0.005 profit in FY 2021). Revenue: AU$31.0m (up 3.2% from FY 2021). Net loss: AU$3.09m (down 219% from profit in FY 2021). Revenue missed analyst estimates by 2.7%. Earnings per share (EPS) also missed analyst estimates by 50%. Over the next year, revenue is forecast to grow 28%, compared to a 12% growth forecast for the Chemicals industry in Australia. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
分析記事 • Jul 15What Does SECOS Group Limited's (ASX:SES) Share Price Indicate?While SECOS Group Limited ( ASX:SES ) might not be the most widely known stock at the moment, it saw significant share...
Price Target Changed • Jul 12Price target decreased to AU$0.20Down from AU$0.29, the current price target is provided by 1 analyst. New target price is 60% above last closing price of AU$0.13. Stock is down 62% over the past year. The company is forecast to post a net loss per share of AU$0.004 compared to earnings per share of AU$0.0051 last year.
Board Change • Jul 12No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 1 highly experienced director. No independent directors (5 non-independent directors). Non-Executive Director Jim Walsh was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Jun 17SECOS Group Limited Announces the Retirement of David Wake as a Non-Executive Director on 30 June 2022The Board of SECOS Group Limited announced that Mr. David Wake will retire as a Non-Executive Director on 30 June 2022. Mr. Wake has served the Company for four years since his appointment on 16 July 2018 and during that time contributed significantly to SECOS' strategic direction, governance and provided valuable advice on industry matters.
お知らせ • May 16+ 1 more updateSECOS Group Limited Appoints Colin Lai Has Been as Chief Financial OfficerSECOS Group Limited announced that Mr. Colin Lai has been appointed as Chief Financial Officer effective 14 June 2022. Colin is a finance and accounting professional with extensive experience in FMCG, financial and software services sectors with public-listed and multinational companies. His most recent role was as Group Financial Controller at BWX Limited with previous group finance roles at National Australia Bank, Iress Ltd. and Treasury Wine Estates.In his BWX role, Colin led a Global Finance Team, and was involved in high level strategic planning and financial decisions, equity raises, and conducting due diligence and financial reviews in connection with acquisitions. He was also involved in successful negotiations of Group debt facilities to support growth initiatives. Colin has managed key areas of finance including financial control and reporting and has significant experience in preparing Group budgets, sales forecasts, analyzing the profitability of new products, evaluation of marketing campaigns, and detailed reviews of marketing and supply chain contracts.
お知らせ • May 12SECOS Group Ordinary Shares to Be Deleted from Other OTCSECOS Group Limited Ordinary Shares will be deleted from Other OTC effective from May 11, 2022, due to Inactive Security.
お知らせ • Apr 20Woolworths Expands SECOS Products to 970 StoresThe Board of SECOS Group provided the market with an update on progress of its MyEcoBag® commercialisation activities. MyEcoTM success within Woolworths stores, together with the expansion into other distributors and retail chains supports the Board's strategic investment decision to expand in the retail market and the extra investment incurred in FY22. These investments are expected to achieve positive returns in the coming year. The availability of SECOS' compostable bags via Woolworths stores will give more households participating in approved council food organic waste programs the option to dispose of the bags and food waste in their green waste bin. The use of SECOS' compostable bags offers households a clean and convenient way to assist with the separation of their food waste which is critical to ensure food does not end up in landfill. The success of MyEcoTM branded products is becoming a material subcategory within the Company's total bioplastic bag sales. The expansion into 970 Woolworths stores has validated the Board's decision to invest extra funds into developing a global retail brand during a period when the Company was experiencing a range of global challenges (Covid-19 related rising freight and input costs, shipping delays, Covid lockdowns in some ports and severe floods experienced at one of the Company's manufacturing hubs). SECOS will continue to execute its growth strategy and expects returns to flow through to the bottom line as trading conditions normalize. The Company will also benefit from improving economies of scale through increased utilisation of the Company's new Malaysian plant which was launched in January this year. SECOS continues to develop further opportunities for growth in new markets for its branded MyEcoBag® and MyEcoPet® line of products and is working to garner market share in grocery and convenience stores in Australia, the USA, Latin America and elsewhere.
お知らせ • Apr 14+ 1 more updateEdmond Tern Decides to Leave SECOS Group Limited as Chief Financial OfficerSECOS Group Limited announced that Mr. Edmond Tern, Chief Financial Officer & Company Secretary, has decided to leave SECOS to pursue other opportunities in early July 2022. An orderly transition including a search for a new CFO & Company Secretary is currently underway.
お知らせ • Apr 12SECOS Group Limited Announces Change of Corporate Head Office AddressSECOS Group Limited announced that it has relocated its corporate head office to Mount Waverley, Victoria. The new head office will be co-located with the company's new Global Bioplastics Research and Development Centre.
Major Estimate Revision • Mar 03Consensus revenue estimates fall by 10%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from AU$43.0m to AU$38.5m. Forecast losses increased from AU$0.01 to AU$0 per share. Chemicals industry in Australia expected to see average net income growth of 33% next year. Consensus price target down from AU$0.45 to AU$0.40. Share price rose 10% to AU$0.27 over the past week.
分析記事 • Feb 28One SECOS Group Limited (ASX:SES) Broker Just Cut Their Revenue Forecasts By 10%The analyst covering SECOS Group Limited ( ASX:SES ) delivered a dose of negativity to shareholders today, by making a...
お知らせ • Jan 24SECOS Launches MyEcoBag® & MyEcoPet® Through Pacchini Sales & DistributionSECOS Group Limited provided the market with an update on progress of its MyEcoBag® and MyEcoPet® commercialization activities. SECOS is launching new MyEcoPet® SKU's with Pacchini consisting of the two-roll pack plus dispenser and the four-roll pack. With nearly 5 million dogs in Australia and approximately 40% of Australian households owning a dog, SECOS will begin to penetrate independent Stores backed by a well-known and reputable distributor such as Pachinni. Additionally, Pacchini will launch two new bin-liner SKU's into food waste diversion market, a certified compostable 12 litre and 28 litre bin liner SKU's, adding to their existing 8 litre and 36 litre SKU's currently available through Woolworths stores.
分析記事 • Oct 05SECOS Group (ASX:SES) Might Have The Makings Of A Multi-BaggerThere are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...
分析記事 • Sep 02We Think Shareholders Should Be Aware Of Some Factors Beyond SECOS Group's (ASX:SES) ProfitAfter announcing healthy earnings, SECOS Group Limited's ( ASX:SES ) stock rose over the last week. However, we think...
Reported Earnings • Aug 13Full year 2021 earnings releasedThe company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: AU$30.1m (up 43% from FY 2020). Net income: AU$2.59m (up AU$3.78m from FY 2020). Profit margin: 8.6% (up from net loss in FY 2020). The move to profitability was driven by higher revenue.
Breakeven Date Change • Jun 30Forecast breakeven pushed back to 2022The analyst covering SECOS Group previously expected the company to break even in 2021. New forecast suggests the company will make a profit of AU$5.70m in 2022. Average annual earnings growth of 103% is required to achieve expected profit on schedule.
分析記事 • Jun 07We Think SECOS Group (ASX:SES) Can Easily Afford To Drive Business GrowthWe can readily understand why investors are attracted to unprofitable companies. For example, SECOS Group ( ASX:SES...
Price Target Changed • May 05Price target increased to AU$0.37Up from AU$0.28, the current price target is an average from 2 analysts. New target price is 72% above last closing price of AU$0.21. Stock is up 264% over the past year.
分析記事 • Apr 06We Might See A Profit From SECOS Group Limited (ASX:SES) SoonWe feel now is a pretty good time to analyse SECOS Group Limited's ( ASX:SES ) business as it appears the company may...
分析記事 • Mar 15Imagine Holding SECOS Group (ASX:SES) Shares While The Price Zoomed 409% HigherIt might be of some concern to shareholders to see the SECOS Group Limited ( ASX:SES ) share price down 18% in the last...
Recent Insider Transactions • Mar 04Executive Director recently bought AU$307k worth of stockOn the 2nd of March, Stephen Walters bought around 1m shares on-market at roughly AU$0.31 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold AU$636k more in shares than they bought in the last 12 months.
Price Target Changed • Feb 24Price target raised to AU$0.28Up from AU$0.23, the current price target is an average from 2 analysts. The new target price is 8.1% below the current share price of AU$0.31. As of last close, the stock is up 313% over the past year.
Analyst Estimate Surprise Post Earnings • Feb 23Revenue beats expectations, earnings disappointRevenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) missed analyst estimates by 90%. Over the next year, revenue is forecast to grow 50%, compared to a 15% growth forecast for the Chemicals industry in Australia.
分析記事 • Feb 22Should You Think About Buying SECOS Group Limited (ASX:SES) Now?While SECOS Group Limited ( ASX:SES ) might not be the most widely known stock at the moment, it received a lot of...
Is New 90 Day High Low • Feb 10New 90-day high: AU$0.35The company is up 100% from its price of AU$0.17 on 12 November 2020. The Australian market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share.
分析記事 • Feb 05Richard Tegoni Is The Executive Chairman of SECOS Group Limited (ASX:SES) And They Just Picked Up 63% More SharesThose following along with SECOS Group Limited ( ASX:SES ) will no doubt be intrigued by the recent purchase of shares...
Recent Insider Transactions • Feb 05Executive Chairman recently bought AU$60k worth of stockOn the 4th of February, Richard Tegoni bought around 200k shares on-market at roughly AU$0.30 per share. This was the largest purchase by an insider in the last 3 months. This was Richard's only on-market trade for the last 12 months.
Is New 90 Day High Low • Jan 21New 90-day high: AU$0.24The company is up 48% from its price of AU$0.17 on 23 October 2020. The Australian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.49 per share.
分析記事 • Jan 19Read This Before Buying SECOS Group Limited (ASX:SES) SharesWe've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
Is New 90 Day High Low • Jan 06New 90-day high: AU$0.21The company is up 19% from its price of AU$0.18 on 08 October 2020. The Australian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.50 per share.
分析記事 • Dec 15If You Had Bought SECOS Group (ASX:SES) Stock Three Years Ago, You Could Pocket A 100% Gain TodayBy buying an index fund, investors can approximate the average market return. But if you pick the right individual...
Is New 90 Day High Low • Nov 18New 90-day high: AU$0.20The company is up 24% from its price of AU$0.17 on 20 August 2020. The Australian market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is AU$0.44 per share.
お知らせ • Sep 24SECOS Group Limited Secures a Strategic Distribution Agreement with Infinite Source of IdeasSECOS Group Limited (‘the Company’) announced that it has secured a strategic distribution agreement with ISOI ‘Infinite Source Of Ideas’. Under the agreement, ISOI will act as the Company's exclusive distributor in Latin America for the sale of CardiaTM Bioplastic resins to local converters. ISOI have already supplied several convertors with CardiaTM resins who have produced compostable bags for major local retailers. Distribution and trials of resins to local converters has resulted in a ramp up of demand with initial commercial orders exceeding $1.5m and due for delivery in the December quarter.
お知らせ • Sep 17SECOS Group Limited announced that it has received AUD 14.861974 million in fundingOn September 16, 2020, SECOS Group Limited (ASX:SES) closed the transaction. The company issued 87,423,379 ordinary fully paid shares for gross proceeds of AUD 14,861,974.43 in the transaction. The transaction included participation from individual investor Don Haller Jr. for 811,920 shares for AUD 138,026.40 and other investors.
お知らせ • Sep 09SECOS Group Limited announced that it expects to receive AUD 15.0008 million in fundingSECOS Group Limited (ASX:SES) announced private placement of 88,240,000 shares at a price of AUD 0.17 per share for gross proceeds of AUD 15,000,800 on September 9, 2020. The transaction will include participation from leading institutions and existing shareholders and a wide group of institutional investors including Don Haller Jr. for $100,000 (AUD 138,402.60), subject to approval of shareholders at annual general meeting. The transaction is expected to settle on September 14, 2020. The transaction has been approved by the board of directors of the company. The transaction was oversubscribed.
お知らせ • Aug 16SECOS Group Limited to Report Q4, 2020 Results on Aug 27, 2020SECOS Group Limited announced that they will report Q4, 2020 results at 10:18 PM, GMT Standard Time on Aug 27, 2020
分析記事 • Aug 11SECOS Group Limited (ASX:SES) Insiders Increased Their HoldingsIt is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
分析記事 • Aug 11Breakeven On The Horizon For SECOS Group Limited (ASX:SES)SECOS Group Limited's (ASX:SES): SECOS Group Limited manufactures and distributes sustainable packaging materials...